Fluoroquinolone resistance linked to GyrA, GyrB, and ParC mutations in Salmonella enterica typhimurium isolates in humans. [electronic resource]
Producer: 20040217Description: 1455-7 p. digitalISSN:- 1080-6040
- Aged
- Anti-Infective Agents -- therapeutic use
- Ciprofloxacin -- therapeutic use
- DNA Gyrase -- drug effects
- Drug Resistance, Multiple, Bacterial -- genetics
- Fluoroquinolones -- therapeutic use
- Humans
- Infant
- Male
- Microbial Sensitivity Tests
- Salmonella Infections -- drug therapy
- Salmonella typhimurium -- drug effects
No physical items for this record
Publication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.